Compare ARK Genomic Revolution ETF (ARKG) vs Chevron Corp (CVX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Chevron Corp — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Chevron Corp trades at $177.56 (market cap $351.32B). The key difference: Chevron Corp pays a 4.04% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Chevron Corp nearer its low. Which is the better fit depends on your goals.
| ARKG | CVX | |
|---|---|---|
Sector | Sector/Thematic | Energy |
52-Week High | $43.57 | $211.14 |
52-Week Low | $23.09 | $146.72 |
Market Cap | — | $351.32B |
Volume | — | 9,807,834 |
Enterprise Value | — | $391.42B |
Dividend Yield | — | 4.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Chevron (CVX) trades at $176.40, up 1.35% today, with a neutral technical signal and strong analyst consensus. Recent earnings beat expectations, though revenue and net income have declined year-over-year. The company maintains solid cash flow from operations and announced a $13.8 billion investment in Argentina. A dividend of $1.78 per share is scheduled for payment on June 10, 2026.
CVX offers value with a consensus price target of $207.56, implying 17.6% upside, supported by high oil prices and strategic expansions. Risks include volatile energy markets, geopolitical tensions affecting supply chains, and declining profit margins. Institutional sentiment remains bullish despite near-term earnings pressure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Chevron Corp
Chevron Corporation is an integrated energy company with operations in countries located around the world. The Company produces and transports crude oil and natural gas. Chevron also refines, markets, and distributes fuels, as well as is involved in chemical and mining operations, power generation, and energy services.
Read more on CVX →
